222 related articles for article (PubMed ID: 30017564)
41. Structural analysis of ribonucleopeptide aptamer against ATP.
Mashima T; Matsugami A; Nakano S; Inoue M; Fukuda M; Morii T; Katahira M
Nucleic Acids Symp Ser (Oxf); 2009; (53):267-8. PubMed ID: 19749363
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
43. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
44. A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.
Zhuang X; Stahl SJ; Watts NR; DiMattia MA; Steven AC; Wingfield PT
J Biol Chem; 2014 Jul; 289(29):20222-33. PubMed ID: 24878961
[TBL] [Abstract][Full Text] [Related]
45. Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transport.
Cao Y; Liu X; De Clercq E
Curr HIV Res; 2009 Jan; 7(1):101-8. PubMed ID: 19149559
[TBL] [Abstract][Full Text] [Related]
46. A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export.
Watts NR; Eren E; Zhuang X; Wang YX; Steven AC; Wingfield PT
J Struct Biol; 2018 Aug; 203(2):102-108. PubMed ID: 29605570
[TBL] [Abstract][Full Text] [Related]
47. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs.
Mikaélian I; Krieg M; Gait MJ; Karn J
J Mol Biol; 1996 Mar; 257(2):246-64. PubMed ID: 8609621
[TBL] [Abstract][Full Text] [Related]
48. An unusual topological structure of the HIV-1 Rev response element.
Fang X; Wang J; O'Carroll IP; Mitchell M; Zuo X; Wang Y; Yu P; Liu Y; Rausch JW; Dyba MA; Kjems J; Schwieters CD; Seifert S; Winans RE; Watts NR; Stahl SJ; Wingfield PT; Byrd RA; Le Grice SF; Rein A; Wang YX
Cell; 2013 Oct; 155(3):594-605. PubMed ID: 24243017
[TBL] [Abstract][Full Text] [Related]
49. A Survey of DDX21 Activity During Rev/RRE Complex Formation.
Hammond JA; Zhou L; Lamichhane R; Chu HY; Millar DP; Gerace L; Williamson JR
J Mol Biol; 2018 Feb; 430(4):537-553. PubMed ID: 28705764
[TBL] [Abstract][Full Text] [Related]
50. The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication.
Sherpa C; Rausch JW; Le Grice SF; Hammarskjold ML; Rekosh D
Nucleic Acids Res; 2015 May; 43(9):4676-86. PubMed ID: 25855816
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
52. Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide.
Ueno M; Kodama EN; Shimura K; Sakurai Y; Kajiwara K; Sakagami Y; Oishi S; Fujii N; Matsuoka M
Antiviral Res; 2009 Apr; 82(1):67-72. PubMed ID: 19428597
[TBL] [Abstract][Full Text] [Related]
53. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
[TBL] [Abstract][Full Text] [Related]
55. Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes.
Edgcomb SP; Aschrafi A; Kompfner E; Williamson JR; Gerace L; Hennig M
Protein Sci; 2008 Mar; 17(3):420-30. PubMed ID: 18218716
[TBL] [Abstract][Full Text] [Related]
56. Native mass spectrometry reveals the initial binding events of HIV-1 rev to RRE stem II RNA.
Schneeberger EM; Halper M; Palasser M; Heel SV; Vušurović J; Plangger R; Juen M; Kreutz C; Breuker K
Nat Commun; 2020 Nov; 11(1):5750. PubMed ID: 33188169
[TBL] [Abstract][Full Text] [Related]
57. Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression.
Yedavalli VS; Jeang KT
Retrovirology; 2011 Jul; 8():61. PubMed ID: 21771347
[TBL] [Abstract][Full Text] [Related]
58. A Rev-CBP80-eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA.
Toro-Ascuy D; Rojas-Araya B; García-de-Gracia F; Rojas-Fuentes C; Pereira-Montecinos C; Gaete-Argel A; Valiente-Echeverría F; Ohlmann T; Soto-Rifo R
Nucleic Acids Res; 2018 Nov; 46(21):11539-11552. PubMed ID: 30239828
[TBL] [Abstract][Full Text] [Related]
59. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
60. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
